Teleflex Medical Launches Hybrid Universal OSA Interface
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Teleflex Medical announced today the launch of the Hybrid™, a revolutionary interface for use with sleep therapy systems for the treatment of obstructive sleep apnea. The Hybrid™ interface is a unique fusion of technologies designed to be a universal interface for patients, clinicians and providers. This one product serves as a nasal interface, an oral interface, and a combination of the two. Its proprietary design enhances patient comfort and compliance by eliminating pressure points on the forehead and across the bridge of the nose.
“We at Teleflex Medical are excited to bring this innovative technology to market,” said Tim Hopper, vice president and general manager of the Medical Products business unit, Teleflex Medical. “The proprietary design of the Hybrid™ redefines the management of obstructive sleep apnea by providing optimal patient comfort resulting in greater therapy compliance. As a result, the Hybrid™ will transform the way OSA management is viewed moving forward.”
The Hybrid™ joins Teleflex Medical’s existing family of Nasal-Aire(R) II sleep therapy interfaces. The Nasal-Aire II features an innovative design that looks, wears and feels like an oversized oxygen cannula. The product is available in standard and petite sizes, making it suitable for a wide range of patients.
Teleflex Medical, a division of Teleflex Incorporated, is a leading global supplier of disposable medical products, surgical instruments and medical devices. The division supports health providers along the continuum of care in three main areas:
— Devices for sleep therapy, respiratory care, anesthesia and
— Surgical instruments, reusable and disposable surgical devices
specializing in ligation and wound closure and devices for
cardiac and thoracic surgery
— Original equipment manufacturers
Teleflex Medical markets health care supplies under the Hudson RCI and Rusch brand names and surgical instruments and medical devices under the Beere, Deknatel, KMedic, Pilling and Weck brands. In 2005, Teleflex Medical had revenues of $831 million.
About Teleflex Incorporated
Teleflex Incorporated (NYSE:TFX) is a diversified company with 2005 annual revenues of $2.5 billion. Teleflex designs, manufactures and distributes quality engineered products and services for the aerospace, automotive, marine, industrial and medical markets worldwide. Headquartered in Limerick, Pa., with operations in 24 countries, Teleflex employs more than 20,000 people worldwide who focus on providing innovative solutions for customers. Additional information about Teleflex can be obtained from the Company’s website on the Internet at www.teleflex.com.
Statements in this news release, other than historical data, are considered forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements are subject to various risks and uncertainties that could cause actual results to differ from those contemplated in the statements. Actual results could differ materially from those in these forward-looking statements; please refer to Teleflex’s filings with the Securities and Exchange Commission.
Hybrid™ is a trademark of RespCare Inc. Nasal-Aire is a registered trademark of InnoMed Technologies, Inc.
Whitney Reynolds, 919-433-4811
SOURCE: Teleflex Medical